Despite extraordinary advances in understanding hypertrophic obstructive cardiomyopathy (HOCM) at the molecular and genetic level, the overall clinical management of patients with HOCM remains ...

Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...

People with symptomatic obstructive hypertrophic cardiomyopathy (HCM) gained functional capacity, and had left ventricular outflow tract (LVOT) gradients reduced, when treated with a cardiac myosin ...

Credit: Getty Images HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C. Hypertrophic cardiomyopathy (HCM) ...

Hypertrophic cardiomyopathy (HCM) thickens the left ventricular muscle, which can limit pumping and relaxation. Many people have no symptoms or only notice issues during exercise. Inherited gene ...

Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UC San Francisco study finds that Artificial Intelligence-enhanced ...

MINNEAPOLIS — Readouts of data on an experimental drug for hypertrophic cardiomyopathies showed the agent appeared safe and effective in long-term treatment and can significantly improve exercise ...

Apical hypertrophic cardiomyopathy is a rare condition where the heart walls thicken at the left ventricle’s apex, making it harder for the ventricle to pump. Symptoms are often vague or absent, but ...